Denemek ALTIN - Özgür

Blood Test For Detecting Cancer

DataQuest

|

November 2019

53% of companies openly admit that limited IT resources are significantly slowing down their digital transformation efforts. Here is how an organization tackles this issue

- Dr. S. Chellaiah

Blood Test For Detecting Cancer

The final and inconclusive proof of the disease is tissue biopsy, a relatively painful process. In certain cases, the tumour is not accessible or the patient is very weak for biopsy. How then do the can oncologists confirm the presence of cancer?

Cancer is a dreaded term in most families. Across the globe, annually about 8 million people die of cancer. In USA alone, every year about 40,000 women die of breast cancer. Mammograms are the best test, yet they often produce false positives, which can warrant unwanted biopsies and surgeries. So called, “high-risk” lesions have abnormal cells and patients are advised surgery. About 90% of the time, the lesion is benign and surgery is an expensive and painful wasted exercise. The final and inconclusive proof of the disease is tissue biopsy, a relatively painful process. In certain cases, the tumour is not accessible or the patient is very weak for biopsy. How then do can oncologists confirm the presence of cancer?

The Research

The research related to cancer is predominantly on two major fronts – 1) to find drugs and ways to treat cancer and 2) to detect cancer at a very early stage where the chances of recovery and remission are high. Typically, people suspect cancer as the cause only when it manifests in some obvious and visible form. Nevertheless, often by then, the disease has progressed to an advanced stage – a stage beyond treatment. Can doctors detect them very early even before the person feels any symptoms? By detecting early, doctors can treat and save many lives and spare many people of anxiety and agony.

Can a simple blood test predict, detect and confirm the presence of cancer? yes, for a few types of cancers it is possible. Colorectal Cancer (CRC) is one for which a blood test is available. Testing the blood for the presence of tumour cells and DNA is a non-invasive approach compared to the invasive biopsy, which is a surgery.

DataQuest'den DAHA FAZLA HİKAYE

DataQuest

DataQuest

The GCC Boom: India's Journey from Cost Arbitrage to Innovation

India's 1,700+ GCCs are shifting from cost to co-creation. Can India convert scale, AI depth, and leadership ambition into true orchestration power for global enterprises?

time to read

16 mins

October 2025

DataQuest

DataQuest

'Je ne sais quoi' is now 'Je ne sais quAl': From metrics to experiences at Genesys Xperience 2025

At Genesys Xperience 2025, CEO Tony Bates showed how agentic AI is shifting businesses from metrics to empathy-driven experiences that build trust.

time to read

8 mins

October 2025

DataQuest

DataQuest

Legacy is not enough: Why enterprises need Al-native SaaS

Phenom's Kiran Menon shares how AI-first SaaS is redefining talent experience, augmenting legacy systems, and delivering measurable outcomes.

time to read

4 mins

October 2025

DataQuest

DataQuest

SAP's Jan Bungert on how business Al and data cloud are powering India's Techade

Jan Bungert, CRO of SAP Business AI, discusses how SAP is embedding AI into core applications and leveraging SAP Business Data Cloud to help Indian enterprises like Parle and Mahindra unlock trusted insights, efficiency, and measurable outcomes.

time to read

4 mins

October 2025

DataQuest

DataQuest

Why the operating system is no longer just plumbing: Raj Das on the future of RHEL

Many enterprises still think of the operating system as a background utility-something you set up once and forget. In reality, modern OS platforms like RHEL are dynamic, intelligent enablers of innovation.

time to read

5 mins

October 2025

DataQuest

DataQuest

Don't bolt Al onto ERP—build a connected system from day one

In an exclusive interaction with Dataquest, Paritosh Ladhani, Joint Managing Director of SLMG Beverages, outlines how the Coca-Cola bottler has moved from legacy processes to a fully digitised, AI-enabled, smart-factory ecosystem.

time to read

10 mins

October 2025

DataQuest

DataQuest

The future isn't about isolated robots

C Balaji, PSG Head, TVS Electronics draws a rough, but realistic, picture of factories that embrace robots for new business models as well as faster (and smarter) assembly lines and packaging. It's an age of managed automation, performance-based services, flexible manufacturing, mass customisation, vision-intelligence, serialisation and traceability across all areas. But would this world be with or without taxes, accidents and retrofitting? Let's take a walk with Balaji around what's changing and what's staying.

time to read

4 mins

October 2025

DataQuest

DataQuest

Hitting 'Reset', Risking 'Reboot' - VMware's Bold Leap from Complexity to Clarity

VMware, under Broadcom, is redefining cloud with VCF 9.0-simplifying portfolios, reshaping partner strategy, and positioning as a product-led platform.

time to read

4 mins

October 2025

DataQuest

DataQuest

Feeding the Al beast, with some beauty

Jameson Mendonca, Power Generation Business Leader, Cummins Power System opens up some pistons of carbon hunger of modern data centres while he also shows how Natural gas, Hydrotreated Vegetable Oil, Life Cycle Assessments (LCAs) and Environmental Product Declarations (EPDs) can weld well in this new era. And why we should we worried about scope 1 and 2 in the race to be no.1 in AI.

time to read

6 mins

October 2025

DataQuest

DataQuest

We allow you to say No!

What's ETA status of real consent, useful personalisation, technology for the everyday commuter and data ethics in the super-busy travel terminal? Anytime now or are we still catching this bus?

time to read

4 mins

October 2025

Translate

Share

-
+

Change font size